Q&A: GSK’s CEO Emma Walmsley on the new Trump administration, trust, AI and Chinanews2024-11-06T18:49:02+00:00November 6th, 2024|Endpoints News|
CVS names Aetna head, plans more pharmacy closures as new CEO takes overnews2024-11-06T16:30:38+00:00November 6th, 2024|Endpoints News|
Novo unveils new cardiometabolic data as it reports solid third-quarter profitsnews2024-11-06T12:05:48+00:00November 6th, 2024|Endpoints News|
Acadia lands $150M sale of rare pediatric PRVnews2024-11-06T12:04:59+00:00November 6th, 2024|Endpoints News|
‘We’re good’ on weight loss: Biopharmas turn to muscle with new obesity drugsnews2024-11-06T12:00:14+00:00November 6th, 2024|Endpoints News|
Cerebral to pay nearly $3.7M over controlled substance prescribing practicesnews2024-11-05T19:34:26+00:00November 5th, 2024|Endpoints News|
Zealand details Phase 1 obesity data for amylin drug as it plans next stepsnews2024-11-05T17:15:38+00:00November 5th, 2024|Endpoints News|
Vertex makes money from sickle cell therapy Casgevynews2024-11-05T12:20:41+00:00November 5th, 2024|Endpoints News|
FDA cites Mark Cuban’s drug compounding center in Dallas with sterility, quality concernsnews2024-11-04T21:14:27+00:00November 4th, 2024|Endpoints News|
The election is Tuesday. What’s at stake for the pharma industry?news2024-11-04T21:07:35+00:00November 4th, 2024|Endpoints News|
